- Home
- PCVX vs KD Comparison
PCVX vs KD Comparison
Compare PCVX & KD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | KD |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | United States | United States |
| Employees | N/A | 80000 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 2.8B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PCVX | KD |
|---|---|---|
| Price | $55.44 | $12.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $98.33 | $35.25 |
| AVG Volume (30 Days) | 1.0M | ★ 3.8M |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 170.95 |
| EPS | N/A | ★ 0.77 |
| Revenue | N/A | ★ $15,057,000,000.00 |
| Revenue This Year | N/A | $3.96 |
| Revenue Next Year | N/A | $0.41 |
| P/E Ratio | ★ N/A | $16.45 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.09 | $10.10 |
| 52 Week High | $76.61 | $43.74 |
Technical Indicators
Market Signals| Indicator | PCVX | KD |
|---|---|---|
| Relative Strength Index (RSI) | 45.44 | 35.85 |
| Support Level | $42.30 | $11.34 |
| Resistance Level | $56.04 | $13.81 |
| Average True Range (ATR) | 2.72 | 0.51 |
| MACD | -0.86 | 0.41 |
| Stochastic Oscillator | 23.13 | 33.81 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About KD Kyndryl Holdings Inc.
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.